Vulnerability in Medtronic Valleylab Exchange Client
CVE-2019-13539
Medtronic Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below use the descrypt algorithm for OS password hashing. While interactive, network-based logons are disabled, and attackers can use the other vulnerabilities within this report to obtain local shell access and access these hashes.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.0 (High). Vector: CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.003 (17.0th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 17th percentile — 17.0% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.003 · newest: 0.003 · change: 0.000
Affected products
- Medtronic Valleylab Exchange Client — versions 0
- Medtronic Valleylab Exchange Client
- Medtronic Valleylab Ft10 Energy Platform
- Medtronic Valleylab Ft10 Energy Platform Firmware
- Medtronic Valleylab Ft10 Energy Platform (Vlft10gen) — versions 0
- Medtronic Valleylab Fx8 Energy Platform
- Medtronic Valleylab Fx8 Energy Platform Firmware
- Medtronic Valleylab Fx8 Energy Platform (Vlfx8gen) — versions 0
Weakness classification (CWE)
References
- www.cisa.gov/news-events/ics-medical-advisories/icsma-19-311-02
- global.medtronic.com/xg-en/product-security/security-bulletins/valleylab-genera…
- af854a3a-2127-422b-91ae-364da2661108 (Third Party Advisory, US Government Resource)
Frequently asked questions
- What is CVE-2019-13539?
- CVE-2019-13539 is a high-severity vulnerability in Medtronic Valleylab Exchange Client, classified under Use of Weak Hash. CVSS score: 7.0/10. Published 2019-11-08.
- How severe is CVE-2019-13539?
- High severity. CVSS v3 base score is 7.0 out of 10.